Predictors of the response to nivolumab immunotherapy in the second or subsequent lines for metastatic non‑small cell lung cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of the response to nivolumab immunotherapy in the second or subsequent lines for metastatic non‑small cell lung cancers

Published:2021-04-14 Issue:6 Volume:21 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Săftescu Sorin¹,Negru Șerban¹,Volovăț Simona²,Popovici Dorel¹,Chercota Vlad³,Stanca Simona⁴,Feier Horea⁵,Malita Daniel ⁶,Dragomir Radu⁷,Volovăț Constantin²

Affiliation:

1. Department of Oncology, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania

2. Department of Oncology, ‘Gr. T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania

3. Department of Ophthalmology, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania

4. Department of Pediatrics, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania

5. Department of Cardiovascular Surgery, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania

6. Department of Radiology and Medical Imaging, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania

7. Department of Obstetrics and Gynecology, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP